MED12 and non-small cell lung carcinoma: Considering that both the PI3K/AKT and MEK/ERK pathways are key downstream signaling pathways directly related to cell proliferation and survival [10, 53], this suggests that the MED12 KO NSCLC cell lines are highly dependent on the MEK/ERK pathway since AKT is already inhibited.